SCHEMBL3891997

SCHEMBL3891997

CC(O)[C@H](NC(C)(C)C)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.39
SLC6A4 P31645 1/20 0.35
CA2 P00918 4/20 0.34
CA1 P00915 3/20 0.34
MME P08473 1/20 0.33
SLC6A3 Q01959 2/20 0.32
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.30
PTGS1 P23219 1/20 0.30
CHRNA1 P02708 1/20 0.30
CHRNG P07510 1/20 0.30
CHRNB1 P11230 1/20 0.30
CHRNB2 P17787 1/20 0.30
SLC6A2 P23975 1/20 0.30
CHRNB4 P30926 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30
CHRND Q07001 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17169784 1.00 TP53 (0.39) TP53SLC6A4CA2CA1MME
SCHEMBL3272876 1.00 TP53 (0.39) TP53SLC6A4CA2CA1MME
SCHEMBL3272882 1.00 TP53 (0.39) TP53SLC6A4CA2CA1MME
Hydrochloric Acid SCHEMBL3653513 0.98 TP53 (0.38) TP53SLC6A4CA2CA1MME
Hydrochloric Acid SCHEMBL3653512 0.98 TP53 (0.38) TP53SLC6A4CA2CA1MME
SCHEMBL15922140 0.85 ALDH1A1 (0.35) TP53SLC6A4SLC6A3ALDH1A1POLB
SCHEMBL6608708 0.83 SMN1; SMN2 (0.37) TP53SLC6A3ALDH1A1
SCHEMBL17245263 0.83 SMN1; SMN2 (0.37) TP53SLC6A3ALDH1A1
SCHEMBL6608711 0.83 SMN1; SMN2 (0.37) TP53SLC6A3ALDH1A1
SCHEMBL28327488 0.81 SMN1; SMN2 (0.43) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2021354-A2 N-TERMINALLY MODIFIED GLP-1 RECEPTOR MODULATORS Brystol-Myers Squibb Company (US) 2009-02-11 EP disclosed
WO-2007140284-A2 N-TERMINALLY MODIFIED GLP-1 RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-06 WO disclosed
EP-1699759-A1 DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY AstraZeneca AB (SE) 2006-09-13 EP disclosed
WO-2005061452-A1 DIPHENYLAZETIDINONE DERIVATES POSSESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-07-07 WO disclosed